Kerri Fitzgerald

DocwireNews

Contrast sensitivity function (CSF) measured using a novel active learning method was significantly decreased in early non-neovascular age-related macular degeneration (nnAMD), according to the results of a study presented by Neal S. Patel, MD, of Massachusetts Eye and Ear, at the American Academy of Ophthalmology 2020 Virtual meeting.According to Dr. Patel, assessments of contrast sensitivity better correlate with functional vision used in day-to-day activities than visual acuity. Indeed, CSF is perhaps an even more accurate measurement of visual function but is difficult to quantify.The absence of a reliable and clinically applicable test has hindered the adoption of CSF testing in routine clinical practice, Dr. Patel and colleagues wrote.Therefore, they developed the Quick Contrast Sensitivity Function (qCSF) method to test CSF. This method uses artificial intelligence with active learning to make the measurement process quicker and more accurate. The model draws from 128 possible contrasts and 19 possible spatial frequencies with a total bank of more than 2,400 candidate test items.According to Dr. Patel, it has high sensitivity, good test-test-reliability, takes about five minutes per eye, and maximizes information gain.To test this new method, Dr. Patel and colleagues measured CSF using qCSF in patients with nnAMD (129 eyes) compared with healthy controls (133 eyes); 31 eyes had early nnAMD, 88 had intermediate nnAMD, and nine had advanced nnAMD. The primary outcome was area under the log contrast sensitivity function curve (AULCSF) and contrast sensitivity threshold at spatial frequencies ranging from one to 18 cycles per degree.Multivariate regression analysis showed that in early nnAMD CSF thresholds at low spatial frequencies were significantly decreased despite no difference in best corrected visual acuity (P&lt;0.01 for all). For intermediate and advanced nnAMD, CSF thresholds at low spatial frequencies and AULCSF were decreased compared with controls (P&lt;0.05 for all).There were no significant differences in higher spatial frequencies identified. In addition, AULCSF was able to differentiate between nnAMD stages.Based on this, &ldquo;CSF may emerge as a promising visual functional endpoint in clinical practice and future nnAMD clinical trials,&rdquo; Dr. Patel and colleagues said on their poster. &ldquo;Future investigations may include longitudinal studies with qCSF tested over progression of macular disease.&rdquo;

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

Active Learning Harnessed to Help Measure Contrast Sensitivity Function in nnAMD

AAO 2020

Contrast sensitivity function (CSF) measured using a novel active learning method was significantly decreased in early non-neovascular age-related macular degeneration ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe